Head to Head Survey: InfuSystem (NYSE:INFU) and Dynatronics (NASDAQ:DYNT)

InfuSystem (NYSE:INFU) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Profitability

This table compares InfuSystem and Dynatronics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Dynatronics	-8.35%	-41.81%	-9.56%

Earnings and Valuation

This table compares InfuSystem and Dynatronics”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$142.40 million	1.26	$870,000.00	$0.38	23.37
Dynatronics	$33.60 million	0.00	-$2.70 million	($1.35)	N/A

InfuSystem has higher revenue and earnings than Dynatronics. Dynatronics is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 10.8% of InfuSystem shares are held by insiders. Comparatively, 2.9% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for InfuSystem and Dynatronics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0	1	2	0	2.67
Dynatronics	0	0	0	0	0.00

InfuSystem currently has a consensus target price of $15.00, suggesting a potential upside of 68.92%. Given InfuSystem’s stronger consensus rating and higher possible upside, equities analysts plainly believe InfuSystem is more favorable than Dynatronics.

Risk & Volatility

InfuSystem has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500.

Summary

InfuSystem beats Dynatronics on 13 of the 13 factors compared between the two stocks.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

About Dynatronics

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.